Wnt/β-Catenin-Pathway Alterations and Homologous Recombination Deficiency in Cholangiocarcinoma Cell Lines and Clinical Samples: Towards Specific Vulnerabilities
Alexander Scheiter(University of Regensburg), Kirsten Utpatel(University of Regensburg)
Cited by 7
Related Papers
Inhibition of MELK Protooncogene as an Innovative Treatment for Intrahepatic Cholangiocarcinoma
|Medicina|2019|13
NADPH oxidase 1/4 dual inhibition impairs transforming growth factor-beta protumorigenic effects in cholangiocarcinoma cancer-associated fibroblasts
|Signal Transduction and Targeted Therapy|2025|8
RASSF1A independence and early Galectin-1 upregulation in PIK3CA induced hepatocarcinogenesis: new therapeutic venues
|bioRxiv (Cold Spring Harbor Laboratory)|2021|1